Isatuximab Quadruplet Approval Could Change the Landscape for Treating MyelomaOctober 7, 2024Multiple MyelomaTransplantation
FDA’s Project Optimus aims to transform early cancer researchNovember 14, 2023PharmacyALLAMLCMLDLBCLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Global data suggest rising CLL incidence since 1990February 25, 2022Leukemia, Myelodysplasia, Transplantation
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaMyelodysplastic SyndromeTransplantation
